We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. Grpel2 maintains cardiomyocyte survival in diabetic cardiomyopathy through DLST-mediated mitochondrial dysfunction: a proof-of-concept study

    Background

    Diabetic cardiomyopathy (DCM) has been considered as a major threat to health in individuals with diabetes. GrpE-like 2 (Grpel2), a...

    Rong** Yang, **aomeng Zhang, ... Pan Chang in Journal of Translational Medicine
    Article Open access 16 March 2023
  2. Comprehensive analysis of miRNA–mRNA regulatory network and potential drugs in chronic chagasic cardiomyopathy across human and mouse

    Background

    Chronic chagasic cardiomyopathy (CCC) is the leading cause of heart failure in Latin America and often causes severe inflammation and...

    Jiahe Wu, Jianlei Cao, ... **aorong Hu in BMC Medical Genomics
    Article Open access 29 November 2021
  3. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity

    Background

    Dilated cardiomyopathy (DCM) is a severe, non-ischemic heart disease which ultimately results in heart failure (HF). Decades of research on...

    Chia Yee Tan, Pui Shi Chan, ... Jianming Jiang in Journal of Translational Medicine
    Article Open access 16 October 2023
  4. Reverse Takotsubo Cardiomyopathy Precipitated by Chronic Cocaine and Cannabis Use

    This case report describes a 31-year-old man with 10 years of cocaine and cannabis dependence who developed reverse Takotsubo cardiomyopathy (rTC), a...

    Emily Nash, Darren M. Roberts, Nazila Jamshidi in Cardiovascular Toxicology
    Article 24 August 2021
  5. Modular networks and genomic variation during progression from stable angina pectoris through ischemic cardiomyopathy to chronic heart failure

    Background

    Analyzing disease–disease relationships plays an important role for understanding etiology, disease classification, and drug repositioning....

    Lin Chen, Ya-Nan Yu, ... Zhong Wang in Molecular Medicine
    Article Open access 26 November 2022
  6. Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis

    Background

    Diabetic cardiomyopathy (DCM) is one of the common cardiovascular complications of diabetes and a leading cause of death in diabetic...

    Cheng Peng, Yanxiu Zhang, ... Yao Zhang in Journal of Translational Medicine
    Article Open access 01 February 2023
  7. Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy

    Cardiomyopathy (CMP) is a heritable disorder. Over 50% of cases are gene-elusive on clinical gene panel testing. The contribution of variants in...

    Robert Lesurf, Abdelrahman Said, ... Seema Mital in npj Genomic Medicine
    Article Open access 14 March 2022
  8. Patient-Specific Modelling and Parameter Optimisation to Simulate Dilated Cardiomyopathy in Children

    Purpose

    Lumped parameter modelling has been widely used to simulate cardiac function and physiological scenarios in cardiovascular research. Whereas...

    Selim Bozkurt, Waleed Paracha, ... Silvia Schievano in Cardiovascular Engineering and Technology
    Article Open access 22 February 2022
  9. Identification and functional characterization of BICD2 as a candidate disease gene in an consanguineous family with dilated cardiomyopathy

    Background

    Familial dilated cardiomyopathy (DCM) is a genetic cardiomyopathy that is associated with reduced left ventricle function or systolic...

    Kai Luo, Chenqing Zheng, ... ** Li in BMC Medical Genomics
    Article Open access 06 September 2022
  10. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Abstract

    Dilated cardiomyopathy (DCM) is the third most common cause of heart failure. The multidisciplinary nature of testing — involving genetics,...

    Marina C. Costa, Maria Calderon-Dominguez, ... Rocío Toro in Journal of Molecular Medicine
    Article Open access 08 September 2021
  11. Toward a diagnostic CART model for Ischemic heart disease and idiopathic dilated cardiomyopathy based on heart rate total variability

    Diagnosis of etiology in early-stage ischemic heart disease (IHD) and dilated cardiomyopathy (DCM) patients may be challenging. We aimed at...

    Agostino Accardo, Luca Restivo, ... Gianfranco Sinagra in Medical & Biological Engineering & Computing
    Article Open access 09 July 2022
  12. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy

    Background

    The aberrant secretion and excessive deposition of type I collagen (Col1) are important factors in the pathogenesis of myocardial fibrosis...

    Hongjie Shi, Ming Yuan, ... **** Liu in Journal of Translational Medicine
    Article Open access 22 March 2024
  13. On the Mechanism of Cardioprotective Effect of Fabomotizole in Alcoholic Cardiomyopathy

    The molecular mechanisms underlying the cardioprotective effect of fabomotizole were studied using the translational rat model of alcoholic...

    S. A. Kryzhanovskii, L. M. Kozhevnikova, ... I. B. Tsorin in Bulletin of Experimental Biology and Medicine
    Article 29 May 2021
  14. A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing

    Background

    Familial dilated cardiomyopathy (DCM) is a genetic heart disorder characterized by progressive heart failure and sudden cardiac death. Over...

    Serwa Ghasemi, Mohammad Mahdavi, ... Samira Kalayinia in BMC Medical Genomics
    Article Open access 07 November 2022
  15. The association between the clinical severity of heart failure and docosahexaenoic acid accumulation in hypertrophic cardiomyopathy

    Objective

    Hypertrophic cardiomyopathy (HCM) is a common genetic disease with diverse morphology, symptoms, and prognosis. Hypertrophied myocardium...

    Keitaro Akita, Kenji Kikushima, ... Yuichiro Maekawa in BMC Research Notes
    Article Open access 14 April 2022
  16. Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis

    As in other cardiomyopathies, extracellular matrix (ECM) remodeling plays an important role in anthracycline-induced cardiomyopathy. To understand...

    Jan M. Leerink, Mabel van de Ruit, ... Wouter E.M. Kok in Journal of Molecular Medicine
    Article Open access 29 May 2021
  17. I536T variant of RBM20 affects splicing of cardiac structural proteins that are causative for develo** dilated cardiomyopathy

    Abstract

    RBM20 is one of the genes predisposing to dilated cardiomyopathy (DCM). Variants in the RS domain have been reported in many DCM patients,...

    Takuma Yamamoto, Rie Sano, ... Hajime Nishio in Journal of Molecular Medicine
    Article Open access 05 October 2022
  18. A circular network of purine metabolism as coregulators of dilated cardiomyopathy

    Background

    The crosstalk of purine biosynthesis and metabolism exists to balance the cell energy production, proliferation, survival and cytoplasmic...

    Ge Wang, Rongjun Zou, ... ** Fan in Journal of Translational Medicine
    Article Open access 18 November 2022
Did you find what you were looking for? Share feedback.